ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.58
-0.46%
US Tech 100
19,111.20
0.22%
S&P 500
5,410.72
-0.42%
US Dollar vs CAD
1.37763
0.24%
Bitcoin
66,914.73
0.24%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sangamo Therapeutics Inc (SGMO)

  7. Sangamo Therapeutics Inc (SGMO) News

SGMO Sangamo Therapeutics Inc

0.55
-0.0066 (-1.19%)
Last Updated: 08:48:57
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Sangamo Therapeutics Inc SGMO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0066 -1.19% 0.55 08:48:57
Open Price Low Price High Price Close Price Previous Close
0.557 0.55 0.572573 0.5566
more quote information »

Recent News

Date Time Source Heading
6/13/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202416:10EDGAR2Form 8-K - Current report
5/29/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/29/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/29/202415:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/29/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202415:01EDGAR2Form 8-K - Current report
5/09/202415:01BWSangamo Therapeutics Reports Recent Business Highlights and..
5/09/202407:05BWSangamo Therapeutics Presents Next-Generation Modular..
5/02/202415:15BWSangamo Therapeutics Announces First Quarter 2024 Conference..
4/22/202415:35BWSangamo Therapeutics to Present Neurology-Focused..
3/22/202407:05BWSangamo Therapeutics Announces Pricing of $24.0 Million..
3/13/202407:05BWSangamo Therapeutics Reports Recent Business Highlights and..
3/13/202407:01BWSangamo Therapeutics Announces Data From Novel Proprietary..
3/12/202417:30BWSangamo Therapeutics Announces Fourth Quarter and Full Year..
2/27/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202407:05BWSangamo Therapeutics Announces U.S. FDA Alignment on..
2/06/202415:35EDGAR2Form 8-K - Current report
2/05/202417:01BWSangamo Therapeutics Announces Updated Phase 1/2 STAAR Study..
1/26/202410:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/24/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202416:09EDGAR2Form 8-K - Current report
12/13/202306:55EDGAR2Form 8-K - Current report
11/28/202315:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202315:02EDGAR2Form 8-K - Current report
11/01/202315:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

NASDAQ
SGMO
Sangamo Therapeutics
USOTC
XFCH
X Factor Communications (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved